Cox AJ - Search Results

1

Angiotensin converting enzyme inhibition reduces retinal overexpression of vascular endothelial growth factor and hyperpermeability in experimental diabetes.

Gilbert RE, Kelly DJ, Cox AJ, Wilkinson-Berka JL, Rumble JR, Osicka T, Panagiotopoulos S, Lee V, Hendrich EC, Jerums G, Cooper ME. Gilbert RE, et al. Among authors: cox aj. Diabetologia. 2000 Nov;43(11):1360-7. doi: 10.1007/s001250051539. Diabetologia. 2000. PMID: 11126403

2

Increased renal expression of vascular endothelial growth factor (VEGF) and its receptor VEGFR-2 in experimental diabetes.

Cooper ME, Vranes D, Youssef S, Stacker SA, Cox AJ, Rizkalla B, Casley DJ, Bach LA, Kelly DJ, Gilbert RE. Cooper ME, et al. Among authors: cox aj. Diabetes. 1999 Nov;48(11):2229-39. doi: 10.2337/diabetes.48.11.2229. Diabetes. 1999. PMID: 10535459

3

SPARC gene expression is increased in diabetes-related mesenteric vascular hypertrophy.

Jandeleit-Dahm K, Rumble J, Cox AJ, Kelly DJ, Dziadek M, Cooper ME, Gilbert RE. Jandeleit-Dahm K, et al. Among authors: cox aj. Microvasc Res. 2000 Jan;59(1):61-71. doi: 10.1006/mvre.1999.2189. Microvasc Res. 2000. PMID: 10625572

4

Endothelin receptor antagonism ameliorates mast cell infiltration, vascular hypertrophy, and epidermal growth factor expression in experimental diabetes.

Gilbert RE, Rumble JR, Cao Z, Cox AJ, van Eeden P, Allen TJ, Kelly DJ, Cooper ME. Gilbert RE, et al. Among authors: cox aj. Circ Res. 2000 Feb 4;86(2):158-65. doi: 10.1161/01.res.86.2.158. Circ Res. 2000. PMID: 10666411

5

Effects of endothelin or angiotensin II receptor blockade on diabetes in the transgenic (mRen-2)27 rat.

Kelly DJ, Skinner SL, Gilbert RE, Cox AJ, Cooper ME, Wilkinson-Berka JL. Kelly DJ, et al. Among authors: cox aj. Kidney Int. 2000 May;57(5):1882-94. doi: 10.1046/j.1523-1755.2000.00038.x. Kidney Int. 2000. PMID: 10792607 Free article.

6

Blockade of the renin-angiotensin and endothelin systems on progressive renal injury.

Cao Z, Cooper ME, Wu LL, Cox AJ, Jandeleit-Dahm K, Kelly DJ, Gilbert RE. Cao Z, et al. Among authors: cox aj. Hypertension. 2000 Oct;36(4):561-8. doi: 10.1161/01.hyp.36.4.561. Hypertension. 2000. PMID: 11040236

7

Decreased matrix degradation in diabetic nephropathy: effects of ACE inhibition on the expression and activities of matrix metalloproteinases.

McLennan SV, Kelly DJ, Cox AJ, Cao Z, Lyons JG, Yue DK, Gilbert RE. McLennan SV, et al. Among authors: cox aj. Diabetologia. 2002 Feb;45(2):268-75. doi: 10.1007/s00125-001-0730-4. Diabetologia. 2002. PMID: 11935159

8

Proteinuria and the expression of the podocyte slit diaphragm protein, nephrin, in diabetic nephropathy: effects of angiotensin converting enzyme inhibition.

Langham RG, Kelly DJ, Cox AJ, Thomson NM, Holthöfer H, Zaoui P, Pinel N, Cordonnier DJ, Gilbert RE. Langham RG, et al. Among authors: cox aj. Diabetologia. 2002 Nov;45(11):1572-6. doi: 10.1007/s00125-002-0946-y. Epub 2002 Sep 25. Diabetologia. 2002. PMID: 12436341 Clinical Trial.

9

Tranilast attenuates vascular hypertrophy, matrix accumulation and growth factor overexpression in experimental diabetes.

Bonnet F, Cao Z, Cooper ME, Cox AJ, Kelly DJ, Gilbert RE. Bonnet F, et al. Among authors: cox aj. Diabetes Metab. 2003 Sep;29(4 Pt 1):386-92. doi: 10.1016/s1262-3636(07)70049-6. Diabetes Metab. 2003. PMID: 14526266

10

Combination therapy with tranilast and angiotensin-converting enzyme inhibition provides additional renoprotection in the remnant kidney model.

Kelly DJ, Zhang Y, Cox AJ, Gilbert RE. Kelly DJ, et al. Among authors: cox aj. Kidney Int. 2006 Jun;69(11):1954-60. doi: 10.1038/sj.ki.5000376. Kidney Int. 2006. PMID: 16557218 Free article.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

332 results

Search Page

Filters